Clobazam
- Product NDC
- 51672-4227
- 11-digit product format
- 516724227
- Labeler code
- 51672
- Product ID
- 51672-4227_1fd3064f-ed73-9de1-e063-6294a90a0d97
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clobazam
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Taro Pharmaceuticals U.S.A., Inc.
- Application
- ANDA210978
- Marketing category
- ANDA
- Marketing start
- 2021-06-30
- Substance
- CLOBAZAM
- Active strength
- 2.5 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clobazam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLOBAZAM | 2.5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2MRO291B4U |
| Rxcui | 1366192 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51672-4227-8 | Clobazam | 120 mL in 1 BOTTLE | SUSPENSION | 120 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-4227 | CLOBAZAM SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 6 | Current NDC, Legacy NDC, 1 package rows | 20240817_fd1e63bf-496c-427c-83b7-6acabc00a5e5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51672-4227-8 | 51672422708 | 120 mL in 1 BOTTLE (51672-4227-8) | 120 ml | 2021-06-30 | 0000-00-00 | No | No | Current |